Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia
- 31 March 2008
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (3) , 379-396
- https://doi.org/10.1016/j.neurobiolaging.2006.10.012
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Treatment of dementia with Lewy bodies and Parkinson's disease dementiaMovement Disorders, 2005
- An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and BehaviorCell, 2005
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- α‐Synuclein pathology does not predict extrapyramidal symptoms or dementiaAnnals of Neurology, 2004
- Mechanisms of regulation of the expression and function of G protein-coupled receptor kinasesCellular Signalling, 2003
- Desensitization of α2A‐adrenoceptor signalling by modest levels of adrenaline is facilitated by β2‐adrenoceptor‐dependent GRK3 up‐regulationBritish Journal of Pharmacology, 2003
- Striatal and extrastriatal dysfunction in Parkinson’s disease with dementia: a 6‐[18F]fluoro‐l‐dopa PET studyBrain, 2002
- β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor StimulationJournal of Biological Chemistry, 2002
- Changes in the expression of G protein‐coupled receptor kinases and β‐arrestin 2 in rat brain during opioid tolerance and supersensitivityJournal of Neurochemistry, 2001
- Enhanced expression of G protein‐coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist‐induced desensitizationBritish Journal of Pharmacology, 1998